$0.307100
-0.04-12.53%
At Close: -
$0.300200
-0.0069-2.25%
After Hours: 6:28 PM EDT
15 minutes delayed
TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-0.74 | $-0.58 | -27.6 % |
Mar 2024 | 2024-05-15 | $-0.65 | $-0.50 | -30.0 % |
Mar 2024 | 2024-04-01 | $-0.93 | $-10.80 | 91.4 % |
Sep 2023 | 2023-11-14 | $-67.20 | $-43.60 | -54.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
TransCode Therapeutics (RNAZ) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-0.74, which missed the estimate of $-0.58.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.